[The antiexudative and anti-edematous action of sympathomimetics].
The anti-exudative and anti-edematous effects and the dose-effect relationship of a-sympathomimetics, especially of l-phenylephrine-HCl (PE), have been demonstrated using as model the rat pad-carrageenan edema and the histamine liberator test, the dosage being administered cutaneously, orally, and intraperitoneally. The beta-receptor activating compound bamethane sulfate was not effective when used on the same models. Evidence of percutaneous penetration of PE was provided both on isolated skin and in viro. PE, when injected intravenously or subcutaneously, produced a rise of blood pressure in experimental animals. When PE was administered orally and cutaneously, it did not, however, alter the blood pressure. The anti-inflammatory and anti-exudative effects remianed unchanged.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002351:Carrageenan / Q000037:antagonists & inhibitors; D004487:Edema / Q000517:prevention & control*; D005122:Exudates and Transudates / Q000187:drug effects*; D005260:Female; D006636:Histamine Release / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D013566:Sympathomimetics / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use
D013566:Sympathomimetics; D002351:Carrageenan
Zur antiexsudativen und antiödematösen Wirkung von Sympathikomimetika.